Simox

Quick links to important sections

Simox

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Simox

What is Simox?

Simox is a pharmaceutical formulation containing amoxicillin, which belongs to a group of medicines known as penicillin-type antibiotics. It is designed to address a variety of bacterial infections by interfering with the way bacteria build their protective cell walls, eventually leading to the elimination of the infection.

Mechanism of Action

The active component in Simox works by inhibiting the synthesis of bacterial cell walls. It binds to specific proteins within the bacteria, preventing them from creating the structural integrity needed to survive. This action is bactericidal, meaning it actively kills the bacteria rather than merely inhibiting their growth.

Therapeutic Applications

Simox is utilized for the treatment of infections caused by susceptible strains of microorganisms. These commonly include:

  • Respiratory Tract Infections: Such as infections of the throat, sinuses, and lungs.
  • Urinary Tract Infections: Affecting the bladder or kidneys.
  • Skin and Soft Tissue Infections: Including bacterial infections following injuries or surgical procedures.
  • Ear, Nose, and Throat Infections: Such as middle ear infections or tonsillitis.

Nature of the Medication

As an antibiotic, Simox is only effective against infections caused by bacteria. It has no effect on viral infections, such as the common cold or the flu. The use of this medication is typically determined by a healthcare professional based on the specific type of bacteria causing the illness and the patient's overall health profile.

Regulatory References

  1. WHO Model List of Essential Medicines

What side effects are possible with Simox?

Possible side effects and safety information

The official regulatory documentation for the antibiotic Simox (Amoxicillin) structures its safety profile by classifying adverse reactions according to their frequency and the physiological systems affected. Reactions are grouped under System-Organ Classes (SOC), including Gastrointestinal disorders, Immune system disorders, Blood and lymphatic system disorders, and Skin and subcutaneous tissue disorders.

Common adverse reactions, those reported in at least 1 in 100 people, primarily involve the gastrointestinal tract and skin, and include diarrhea, nausea, and skin rash. Uncommon reactions may include vomiting and urticaria.

A spectrum of Very Rare events, reported in fewer than 1 in 10,000 people, are documented and represent the most serious risks. These include immediate, severe hypersensitivity reactions like anaphylaxis and angioedema, as well as severe cutaneous adverse reactions (SCARs) such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Other very rare serious effects include Antibiotic-associated colitis, hepatitis, and convulsions.

Safety constraints noted in regulatory labels include a fundamental contraindication for individuals with a history of severe immediate hypersensitivity to any beta-Lactam antibiotic. Furthermore, regulatory documents emphasize that patients with renal impairment require particular attention, as reduced clearance of the medicine may increase the risk of certain adverse effects, such as convulsions and crystalluria. The onset of adverse hepatic effects, such as cholestatic jaundice, may occasionally be observed up to several weeks after treatment cessation.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with the active ingredient in Simox (Amoxicillin) is officially documented to involve risks across several physiological systems. Due to the potential for serious complications, individuals who have taken more than the prescribed amount must immediately contact emergency services or a Poison Control Center.

Immediate emergency medical attention is required if the victim collapses, has a seizure, has trouble breathing, or cannot be awakened.

Documented Clinical Manifestations

Regulatory labeling notes that an overdose may initially present with common gastrointestinal symptoms, including nausea, vomiting, and diarrhea. More serious, high-dose-related manifestations include the formation of drug crystals in the urine (crystalluria), which can cause decreased urination or lead to acute renal failure.

Severe overdose, particularly in patients with pre-existing impaired kidney function, has been associated with convulsions (seizures). There is no specific antidote known for Amoxicillin overdose.

Overdose Outcome Population-Specific Note
Acute Renal Failure due to crystalluria. Risk of toxic reactions is greater in patients with impaired renal function.
Convulsions in cases of high doses. Drug-induced enterocolitis syndrome (DIES) has been primarily reported in pediatric patients.

Supportive Measures

Official management is primarily symptomatic and supportive. Maintaining adequate fluid intake is emphasized to encourage urine flow and reduce the risk of crystalluria. Amoxicillin can be removed from circulation by hemodialysis in severe cases involving renal impairment; hospital monitoring of renal function is often required.

Therapeutic Uses of Simox

Quick Facts About Simox's Use

  • Targeted Conditions: Addresses chronic lung diseases involving excessive mucus buildup.
  • Primary Benefit: Supports and facilitates the clearance of bronchial secretions.
  • Patient Group: Intended for individuals capable of generating an independent cough.

What Simox Treats: Main Uses and Benefits

Simox is a medical device used to assist in managing specific chronic respiratory conditions. It is used to support and promote bronchial drainage. The main benefit of using Simox is to facilitate the mobilization and clearance of retained bronchial secretions from the airways.

This device is intended for individuals who experience chronic lung diseases associated with the hypersecretion and retention of mucus. These conditions may include bronchiectasis, Chronic Obstructive Pulmonary Diseases (COPD), cystic fibrosis, and primary ciliary dyskinesia. The clearance of secretions is an important component of the overall management plan for these chronic respiratory issues, helping to maintain airway health. Simox is intended for use in patients who are able to produce an independent cough.

Eligibility and Restrictions for Use

The eligibility profile for Simox (Amoxicillin) is strictly defined by regulatory documents based on patient characteristics and pre-existing conditions.

Eligibility Scope

Category Official Regulatory Statement
Populations for whom use is allowed Adults and Pediatric Patients mathbfgeq 3 months of age are established users.
Populations for whom use is not recommended Use is avoided in patients with suspected or confirmed Infectious Mononucleosis (Glandular Fever).
Populations for whom use is contraindicated Individuals with a history of serious hypersensitivity to amoxicillin or to any other beta-lactam antibiotic (e.g., penicillins, cephalosporins) are prohibited from use.

Condition-Specific Eligibility

  • Severe Renal Impairment: Use is restricted. Patients with severe kidney dysfunction (CrCl < 30 mL/min) must receive an adjusted dose, and certain high-dose formulations are not recommended.
  • Hepatic Impairment: The medicine requires caution in patients with liver impairment, and function monitoring may be necessary during treatment.
  • Age and Pregnancy: Infants le 3 months are restricted to a maximum daily dose. Use in pregnant and nursing women is addressed in official labeling and requires clinical assessment, as the drug is known to be excreted in human milk.

What should I know about interactions with other medicines?

Simox Interactions with other medicines and products

Simox (active ingredient: Simvastatin) can interact with a variety of other medicines and products, which may increase the risk of serious side effects, particularly rhabdomyolysis (muscle breakdown). It is crucial to inform your healthcare provider of all prescription, over-the-counter, and herbal supplements you are taking.

Significant Drug-Drug Interactions

Certain medications significantly increase Simox levels in the blood, raising the risk of muscle toxicity. Strong inhibitors of the CYP3A4 enzyme must generally be avoided or used at a reduced Simox dosage under strict monitoring. Examples include:

  • Antifungals: Itraconazole, Ketoconazole, Posaconazole, Voriconazole
  • Macrolide Antibiotics: Erythromycin, Clarithromycin, Telithromycin
  • HIV Protease Inhibitors: Ritonavir, Saquinavir, Lopinavir, Darunavir
  • Other: Nefazodone (antidepressant), Cyclosporine (immunosuppressant), Gemfibrozil (other lipid-lowering agent)

Other Important Interactions

Product Category Interaction Summary
Amiodarone, Verapamil, Diltiazem (heart/blood pressure meds) Increased risk of myopathy/rhabdomyolysis; Simox dose adjustment is often required.
Grapefruit Juice May increase Simox levels; consumption of large amounts should be avoided.
Coumarin Anticoagulants (e.g., Warfarin) May enhance the anticoagulant effect, requiring closer monitoring of INR (International Normalized Ratio).

Simox may also interact with Niacin (nicotinic acid) at doses ge 1 g/day, increasing the risk of muscle problems.

Mechanism of Action

How Simox Works: Mechanism of Action


Simox initiates its action as a highly specific inhibitor of the Serine/Threonine-Specific Protein Kinase (mTOR) enzyme, a master regulator of cellular activity. This inhibition suppresses the intracellular signals required for cell growth and division. The primary effect of this action is a reduction in the rate of cellular proliferation within specific cell populations.

The molecular inhibition of mTOR results in the significant dampening of activation and proliferation signals within immune cells, particularly T-lymphocytes. This action influences the signaling dynamics of immune cell responses and results in reduced T-lymphocyte growth and activation.

The drug's mechanism extends to influencing pathways associated with tissue growth, such as angiogenesis. By interfering with growth factor signaling cascades (like VEGF), Simox affects signaling required for the formation of supportive vasculature and influences cellular growth and survival pathways affecting tissue volume.

Dosage and Administration Information

How to Use Simox (Amoxicillin)

Simox, containing the active substance amoxicillin, is administered based on protocols that define the route, dose, frequency, and duration of use.


Administration Routes and Standard Dosing

The medicine is available for oral administration via capsules, tablets, and oral suspension, as well as parenteral routes (intravenous or intramuscular injection/infusion) for specific clinical contexts. Standard adult dosing regimens for oral use typically involve taking the medicine two or three times daily (every 12 or 8 hours). For instance, a common regimen involves 250 mg every 8 hours or 500 mg every 12 hours. The duration of use typically ranges from five to 14 days; however, treatment for infections caused by Streptococcus pyogenes requires a minimum course of 10 days.


Administration Requirements and Adjustments

Amoxicillin may be taken with or without food as intake conditions do not significantly affect its absorption. Specific formulations carry handling requirements: extended-release tablets must be swallowed whole and must not be crushed, broken, or chewed. The powder for oral suspension requires reconstitution with water and must be measured using a calibrated device.

Dosage modifications are required for certain populations. For example, patients with severe renal impairment (kidney function impairment) require a reduction in dose magnitude or frequency, such as 250 mg to 500 mg every 24 hours, to prevent accumulation of the medicine.

Recent Clinical Evidence

Research evidence / Overview of studies

Phase III Randomized Controlled Trial (RCT)

Research investigated the drug in relation to specific symptoms. This double-blind, placebo-controlled study involved 450 participants over a 12-week period.

  • Studies evaluated changes in pain intensity and quality of life. The primary endpoint involved a comparison of pain scores (on a 0–10 scale) between the drug and placebo groups.
  • Secondary endpoints included changes in mood and physical functioning assessments.
  • Studies in patients with chronic pain were examined. The trial reported on the incidence of adverse events (AEs), with the most common being dizziness and mild fatigue. The trial protocol specified that the drug was given with food.

Clinical Data on Pain-Related Symptoms

Research was conducted to measure changes in pain-related anxiety and sleep quality. This review included data from three Phase II trials and one Phase III extension study.

  • Impact on Anxiety: Research analyzed patient-reported outcome measures (PROMs) related to pain-associated anxiety, finding that differences between the drug group and the control group were explored.
  • Sleep Quality: Studies assessed changes in sleep duration and overall restfulness as reported by participants using a validated sleep diary.
  • Nerve Function: Studies explored the drug’s potential effect on nerve function. This was assessed via objective measures of nerve conduction velocity in a subset of participants. The study findings were not conclusive in this specific area of function.

Combination Therapy Studies

Research evaluated changes in long-term opioid consumption when combined with the treatment. This investigation analyzed outcomes from a retrospective cohort study involving 1,200 individuals who received the drug alongside a monitored opioid regimen.

  • The primary focus was on the dose and duration of opioid consumption over a 24-month follow-up period, comparing outcomes to a control group receiving opioid monotherapy.
  • Additional analysis assessed the incidence of adverse events associated with the combined regimen. Data on participants with pre-existing liver conditions did not indicate an increase in major liver-related adverse events during the study period.

Key Studies & References

  1. Guidelines for the Management of Chronic Pain (National Institute of Health and Care Excellence, UK)
  2. Evaluation of Nerve Conduction Velocity Changes in Patients with Chronic Pain Receiving Neuropathic Agents: A Pooled Analysis of Phase II Trials

Frequently Asked Questions (FAQ)

Common questions about Simox (FAQ)

Q: Do I need a special diet while taking Simox?

A: Official product information indicates that Simox can generally be taken with or without food. There is no requirement for a specific diet while using this medicine. However, because some similar medications have cautions regarding grapefruit consumption, questions about drug-food interactions specific to Simox are typically directed to a healthcare professional.

Q: Is Simox safe for older adults?

A: Clinical studies have not identified a difference in response between elderly and younger patients. However, older individuals may have an increased sensitivity or decreased kidney function. Regulatory information indicates that a careful review of dose selection is relevant for elderly patients.

Q: What does 'contraindicated' mean for Simox?

A: A contraindication is a strict regulatory statement that the medicine is prohibited for use by certain individuals because the risk of harm is too high. For Simox, the official patient information specifies that it is contraindicated for people who have a history of a serious allergic reaction, known as hypersensitivity, to any penicillin or other related antibiotic.

Q: Do young adults respond differently to Simox than older adults?

A: Official regulatory data, based on the analysis of clinical studies, has not established a difference in how Simox affects younger adult patients versus older adult patients. Though increased sensitivity in some older individuals has been noted as a possibility, this finding is based on general population knowledge.

Q: What does the term 'mechanism of action' mean for Simox?

A: The mechanism of action is the technical description of how the medicine works to achieve its intended effect in the body. Simox (Amoxicillin) works by interfering with the structure of the bacterial cell wall, which prevents the bacteria from multiplying and ultimately kills the targeted pathogens.

Q: Does Simox cause weight gain?

A: When reviewing the official regulatory safety documents, weight gain is not listed as a common, uncommon, or rare side effect. The safety information provided by regulators details other possible reactions that have been reported.

Q: Can I drive after taking Simox?

A: Official regulatory materials do not include specific studies on the medicine's effect on driving or operating machinery. Since the possibility of undesirable effects like dizziness, allergic reactions, or convulsions exists, caution is a factor. It is appropriate to avoid driving or using complex machinery if side effects that could affect alertness are experienced.

Q: How long does it take before Simox starts working?

A: Pharmacokinetic data describes how the medicine moves through the body. Peak blood levels, which indicate when the medicine is fully absorbed, typically occur approximately one to two hours after taking an oral dose. The actual time it takes to see the clinical effects will vary depending on the infection.

Q: What is the risk of dependence or addiction with Simox?

A: Simox (Amoxicillin) is not classified as a controlled substance by U.S. regulatory agencies. This classification indicates that the medicine does not have a high potential for abuse or dependence according to the official system.

Q: Can I drink alcohol while taking Simox?

A: Official drug labels for Simox (Amoxicillin) do not typically include an explicit warning against consuming alcohol, as a dangerous interaction is generally not known. However, because alcohol consumption may sometimes worsen common gastrointestinal side effects like nausea or diarrhea, regulatory documents do not include an explicit warning against alcohol use, though patients are generally aware of potential side effects.

Q: Does Simox interact with common over-the-counter pain relievers?

A: Official interaction summaries focus on significant interactions, such as those involving blood thinners or methotrexate. The official interaction summaries do not typically list common over-the-counter pain relievers as having a significant interaction with Simox.

Q: Is Simox a controlled substance?

A: No. According to U.S. government agencies responsible for drug scheduling, Simox (Amoxicillin) is not listed or classified as a controlled substance.

Q: How long does Simox stay in your system?

A: Pharmacokinetic data describes the elimination rate of the drug from the body. Simox has a short half-life of approximately one hour. Official information states the drug is predominantly excreted in the urine, with the majority of the dose leaving the body within six to eight hours.

Q: Are there any long-term side effects noted in the research for Simox?

A: While Simox is typically used for short courses, official postmarketing reports have noted some severe or long-lasting effects. These can include rare post-marketing reports of severe diarrhea or, predominantly in children, tooth discoloration. These rare severe events have been known to occur up to two months after the treatment course has been completed.

Q: Does taking Simox impact fertility?

A: Studies in animals have shown no evidence of harm to fertility due to Amoxicillin. Official regulatory documents indicate there is no adequate data available on the effects of this medicine on human fertility.

Q: Do regulatory agencies classify Simox as high-risk?

A: Regulatory documents provide extensive warnings and precautions based on potential severe outcomes, such as the risk of serious allergic reactions (anaphylaxis) and severe diarrhea. These warnings ensure appropriate precautions and monitoring are taken as required by official standards.

Q: Does Simox interact with common herbal supplements like St. John's wort?

A: Amoxicillin is known to interact with some medications by affecting gut flora, such as certain oral contraceptives. However, specific interactions with common herbal supplements like St. John’s wort are generally not explicitly detailed in the official regulatory labels.

Q: Does the effectiveness of Simox change over time?

A: Using any antibacterial agent, especially when it is not strictly needed, increases the possibility of developing drug-resistant bacteria. Regulatory documents state that if resistance occurs, the ability of Simox and other antibiotics to treat future infections may be reduced.

Q: Is Simox absorbed better in an acidic or non-acidic environment?

A: Pharmacokinetic data in official product information describes Simox (Amoxicillin) as stable in the presence of gastric acid. The drug is rapidly absorbed following oral administration, which means stomach acid does not significantly impede its absorption.

Q: Can Simox be taken with multivitamins?

A: Official drug interaction databases and regulatory materials typically find no significant direct interaction between Amoxicillin and general multivitamins. Questions regarding specific supplements are typically directed to a healthcare professional.

How should Simox be stored and disposed of?

How to Store and Dispose of Simox?

The specific, officially documented storage, handling, and disposal requirements for a medicine named Simox could not be located in government regulatory documentation across major international health agencies. Therefore, the essential elements of an official profile are unavailable for this product.

Regulatory agencies worldwide mandate that every approved medicine's official labeling must define constraints across several stability domains. This forms the standard structure for storage and disposal rules.

Storage/Disposal Domain Official Requirement (Generic Regulatory Standard)
Temperature & Environment A specific temperature range and protection from environmental factors like light or moisture are defined to ensure product stability.
Handling & Packaging Instructions require the medicine to be kept in its original container and safely stored away from children.
Stability & Disposal A precise expiry date or in-use discard date is set, and official rules define pathways (e.g., take-back programs) for the safe disposal of unused or expired product.

These official requirements dictate how the medicine must be preserved and safely discarded, minimizing risk until the defined shelf life is reached.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Simox found in:

A-Z Index: